Pay in 4 interest-free payments of $6.41 Learn more
Ships within 48 hours · Estimated delivery Oct 2 - Oct 7
Requires low-temperature storage to maintain molecular stability
Direct and indirect healthcare costs related to obesity are more than $1.7 trillion annually
The bio-availability of the DPP-4 inhibitors is very good and the pharmacodynamic- as well as the pharmacokinetic characteristics lead to the above mentioned clinically sufficient DPP-4 inhibition with once daily dosing (only vildagliptin has to be dosed twice daily) (18, 19)
1 2 3 4 "GLP-1 drugs are transforming diabetes, obesity and more
FDA, U.S
This study confirms that composite dietary fiber alleviates obesity-induced muscle atrophy in a gut microbiota-dependent manner
